Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CNO Financial Group, Inc. (NYSE: CNO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a life and health insurer and financial services provider focused on middle-income America, CNO uses its filings to present detailed information on its insurance products, capital position and operating performance.
Investors can review CNO’s current reports on Form 8-K, which the company uses to furnish quarterly earnings press releases, quarterly financial supplements and additional financial and operating data. These filings commonly include metrics such as net income, net operating income, income from insurance products across annuity, health and life lines, fee income, investment income not allocated to product lines, and measures like book value per share and operating return on equity.
Over time, CNO’s SEC filings also provide insight into capital management and structure, including common stock dividends, share repurchase activity, reinsurance transactions with its wholly owned Bermuda reinsurance company, and technology modernization initiatives such as the TechMod project. Filings may describe changes in business mix, such as the decision to exit the fee services side of the Worksite Division to focus on core insurance offerings.
On Stock Titan, AI-generated highlights help explain the key points in lengthy documents, so users can quickly understand what each filing means for CNO’s insurance operations, investment portfolio and shareholders. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while tools for viewing insider-related information, capital actions and recurring reporting patterns make it easier to analyze CNO’s regulatory history.
CNO Financial Group executive Scott L. Goldberg reported equity award activity. On February 10, 2026, he acquired 26,071 shares of common stock at
On the same date, 8,185 common shares were surrendered to CNO to cover required tax withholding on the vested performance share units, leaving 198,724 common shares beneficially owned directly. Goldberg also received 15,800 restricted stock units at
CNO Financial Group’s President, Consumer Division reported an amended insider transaction. On February 10, 2023, the officer exercised employee stock options for 17,095 shares of common stock at $16.42 per share, then sold 17,095 shares at a weighted average price of $25.3397 under a Rule 10b5-1 trading plan adopted on November 11, 2022. Following these transactions, the officer directly beneficially owned 137,305 shares of CNO common stock. The amendment also corrects the presentation of the option exercise and the post-transaction share balance, and notes the options had vested on February 25, 2018 and were scheduled to expire on February 25, 2025.
CNO Financial Group Chief Executive Officer and director Gary C. Bhojwani reported equity compensation activity. On February 10, 2026, he acquired 152,542 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 performance metrics.
On the same date, 64,164 shares of common stock were disposed of at $43.05 per share to satisfy required tax withholding on the vested performance share units. He also received a grant of 81,600 restricted stock units at no cost, which convert one-for-one into common stock and vest in three equal annual installments beginning March 25, 2027, subject to continued employment.
CNO Financial Group General Counsel Matthew J. Zimpfer reported multiple equity award transactions. On February 10, 2026, he acquired 25,384 shares of common stock upon vesting of performance share units and surrendered 7,663 shares to cover tax withholding. He also received 14,300 restricted stock units, which convert one-for-one into common stock and vest in three equal annual installments beginning March 25, 2027.
On February 12, 2026, he exercised an employee stock option for 30,970 shares at an exercise price of $21.06 per share, then sold 30,970 shares of common stock at a weighted average price of $42.9313 per share under a pre-established Rule 10b5-1 trading plan. After these transactions, he directly owned 307,937 shares of common stock.
CNO Financial Group officer Karen J. DeToro, President of the Worksite Division, reported equity compensation changes. On February 10, 2026, she acquired 13,835 shares of common stock at
On the same date, 6,135 shares were surrendered back to CNO Financial at
CNO Financial Group’s Chief Human Resources Officer, Yvonne K. Franzese, reported equity compensation activity. On 02/10/2026 she acquired 19,210 shares of common stock upon vesting of performance share units tied to 2023–2025 operating and shareholder return metrics, and 7,090 shares were surrendered back to the company to satisfy tax withholding.
Franzese also received a new grant of 10,800 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, subject to continued employment. After these transactions she directly holds 33,262 common shares and 44,062 RSUs, and indirectly holds 78,279 common shares through the Yvonne K. Franzese Revocable Trust.
CNO Financial Group’s Chief Investment Officer Eric R. Johnson reported equity compensation activity on common stock. On February 10, 2026, he acquired 25,384 shares of common stock at
On the same date, he disposed of 11,373 shares at
Following these transactions, Johnson directly owns 684,969 shares of common stock and holds 700,269 restricted stock units. The new restricted stock units vest in three equal annual installments beginning on
CNO Financial Group Chief Accounting Officer Joel T. Koehneman received a grant of 2,100 restricted stock units on February 10, 2026. These units were awarded at a price of $0 per unit and increased his directly held restricted stock unit balance to 5,292.
The restricted stock units convert into common stock on a one-for-one basis. They vest in three equal annual installments beginning March 25, 2027, as long as Koehneman remains employed by CNO Financial Group or one of its subsidiaries.
CNO Financial Group Chief Operations Officer Jeanne L. Linnenbringer reported equity compensation activity on common stock and restricted stock units. On February 10, 2026, she acquired 5,830 shares of common stock at $43.05 upon vesting of performance share units tied to 2023 operating return on equity, operating earnings per share, and three-year relative total shareholder return for 2023-2025.
On the same date, 2,752 common shares at $43.05 were surrendered to CNO to cover required tax withholding on the vested performance share units. She also received a grant of 3,600 restricted stock units at $0, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, subject to continued employment.
CNO Financial Group Chief Financial Officer Paul H. McDonough reported equity compensation changes. On February 10, 2026, he acquired 42,309 shares of common stock upon vesting of performance share units tied to 2023–2025 financial and shareholder return metrics, then surrendered 15,374 shares to CNO to satisfy tax withholding at $43.05 per share. He also received a grant of 25,600 restricted stock units at no cost, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, subject to continued employment. Following these transactions, he beneficially owned 248,002.077 shares of common stock directly.
FAQ
What is the current stock price of Cno Finl Group (CNO)?
What is the market cap of Cno Finl Group (CNO)?
